IONS
Ionis Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.6% ·
aandelenstroom +0.1% ·
netto nieuwe posities +5.3%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 137 | +2 | 148.57M | $11.08B | +6 | −5 |
| Q1 2026 | 139 | -2 | 142.62M | $9.86B | +6 | −9 |
| Q4 2025 | 142 | 0 | 143.10M | $10.36B | +1 | n/a |
| Q3 2025 | 25 | +4 | 95.56M | $6.25B | +5 | −2 |
| Q2 2025 | 19 | +1 | 95.25M | $3.76B | +1 | n/a |
| Q1 2025 | 15 | -1 | 43.90M | $1.32B | +1 | −2 |
| Q4 2024 | 16 | -1 | 43.25M | $1.51B | n/a | −1 |
| Q3 2024 | 16 | -1 | 34.86M | $1.40B | n/a | −1 |
| Q2 2024 | 17 | n/a | 24.68M | $1.18B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 23.64M | n/a | $934.13M | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 2 | The Vanguard Group ✦ (passief) | 16.71M | n/a | $660.40M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Capital World Investors ✦ | 12.54M | +1.4% | $495.46M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 10.90M | n/a | $430.54M | 0.0% | n/c | 1 | SEC ↗ ×23 |
| 5 | Wellington Management ✦ | 6.35M | -24.6% | $250.72M | 0.0% | ▼ Trim | 5 | SEC ↗ ×9 |
| 6 | State Street Global Advisors ✦ (passief) | 4.53M | -6.5% | $179.00M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 7 | Adage Capital Partners ✦ | 3.80M | +253.3% | $150.14M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 3.13M | -4.3% | $123.51M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 9 | Tweedy, Browne ✦ | 2.89M | -3.1% | $114.26M | 10.6% | ▼ Trim | 5 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 2.89M | +1.7% | $114.25M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Millennium Management ✦ | 2.65M | +317.0% | $104.68M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 1.79M | +6.1% | $70.66M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 1.49M | -57.0% | $59.07M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | ARK Investment Management ✦ | 900.32K | -10.0% | $35.57M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 15 | Norges Bank ✦ (passief) | 450.25K | -47.5% | $17.79M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 292.65K | +1.9% | $11.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 270.71K | +76.3% | $10.70M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 14.28K | Nieuw | $564,163 | 0.0% | New | 1 | SEC ↗ |
| 19 | Marshall Wace ✦ | 13.10K | +43.9% | $517,581 | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Gotham Asset Management | $564,163 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 490 houders, 170.17M aandelen, $11.94B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.